Search - tctmd.com

Displaying 961 - 980 of 1091

Sort: Relevancy | Date

Presentation TCT 2012

Cases 5 and 6: FFR in Left Main Disease: From Simple Ostial to Complex

Presenter: Soo-Jin Kang

October 25, 2012

Presentation TCT 2012

Case 3: FFR and Left Main Disease

Presenter: Michalis Hamilos

October 25, 2012

Presentation TCT 2012

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

Presenter: Dean Kereiakes

October 25, 2012

Presentation TCT 2012

FFR Decision-Making in a Patient with Left Main Disease and Atrial Septal Defect

Presenter: Naoto Inoue

October 25, 2012

News Industry News

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

October 25, 2012

Presentation TCT 2012

Patient with STEMI, Proximal LAD Occlusion, and Complex Left Main/Multivessel Disease: How to Treat?

Presenter: Jacek Legutko

October 24, 2012

Presentation TCT 2012

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Presenter: Julinda Mehilli

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

October 24, 2012

News Conference News TCT 2012

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

October 24, 2012

Presentation TCT 2012

TCT-66. Impact of Residual Chronic Total Occlusion of Right Coronary Artery on the Long Term Outcome in Patients Treated for Unprotected Left Main Disease: The MIlan and...

Presenter: Kensuke Takagi

October 23, 2012

Presentation TCT 2012

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

Presenter: Renato Valenti

October 23, 2012

Presentation TCT 2012

TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and...

Presenter: Giulio Stefanini

October 23, 2012

Presentation TCT 2012

TCT-42. Long-term Safety and Efficacy of Percutaneous Coronary Intervention with Stenting and Coronary Artery Bypass Surgery for Left Main Disease: Final Five-year Follow-up...

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

Multivessel Disease and Left Main Intervention: Indications and Outcomes

Presenter: David Holmes Jr

October 23, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

Presentation TCT 2012

Stroke After PCI vs. CABG (All Patients and Left Main Disease)

Presenter: Tullio Palmerini

October 22, 2012

Presentation TCT 2012

Simplifying PCI of Left Main Trifurcation Disease

Presenter: Antonio Colombo

October 22, 2012

Presentation TCT 2012

Ostial Left Main Disease: Techniques to "Nail" the Ostium

Presenter: Andrejs Erglis

October 22, 2012

Presentation TCT 2012

Case 2: Left Main Disease Plus Triple-Vessel Disease and Syntax Score <32: PCI vs. CABG

Presenter: Mauro Carlino

October 22, 2012

Advertisement

Cases 5 and 6: FFR in Left Main Disease: From Simple Ostial to Complex

Case 3: FFR and Left Main Disease

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

FFR Decision-Making in a Patient with Left Main Disease and Atrial Septal Defect

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

Patient with STEMI, Proximal LAD Occlusion, and Complex Left Main/Multivessel Disease: How to Treat?

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

TCT-66. Impact of Residual Chronic Total Occlusion of Right Coronary Artery on the Long Term Outcome in Patients Treated for Unprotected Left Main Disease: The MIlan and...

TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI...

TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and...

TCT-42. Long-term Safety and Efficacy of Percutaneous Coronary Intervention with Stenting and Coronary Artery Bypass Surgery for Left Main Disease: Final Five-year Follow-up...

Multivessel Disease and Left Main Intervention: Indications and Outcomes

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Stroke After PCI vs. CABG (All Patients and Left Main Disease)

Simplifying PCI of Left Main Trifurcation Disease

Ostial Left Main Disease: Techniques to "Nail" the Ostium

Case 2: Left Main Disease Plus Triple-Vessel Disease and Syntax Score <32: PCI vs. CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content